James has worked for the Clinigen Group since 2005 and has previously occupied several roles across the Clinical Services and Unlicensed Medicine business units. He established Clinigen’s US office in 2008 to support the Clinical Services business and currently holds the role of Director of Corporate Development.
In this role, his responsibilities include business development and corporate strategy. Having spent over 10 years in the Clinical Services business he continues to work with clients and colleagues to design and deliver safe, secure and cost-effective drug supply and sourcing strategies, and since Clinigen’s acquisition of CSM in 2018 on combining this with innovative approaches to clinical packaging, labeling, and distribution.